Bigner DD - Search Results

1

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.

Thompson EM, Keir ST, Venkatraman T, Lascola C, Yeom KW, Nixon AB, Liu Y, Picard D, Remke M, Bigner DD, Ramaswamy V, Taylor MD. Thompson EM, et al. Among authors: bigner dd. Neuro Oncol. 2017 Sep 1;19(9):1217-1227. doi: 10.1093/neuonc/nox033. Neuro Oncol. 2017. PMID: 28379574 Free PMC article.

2

Medulloblastoma: tumor biological and clinical perspectives.

Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD. Friedman HS, et al. Among authors: bigner sh, bigner dd. J Neurooncol. 1991 Aug;11(1):1-15. doi: 10.1007/BF00166992. J Neurooncol. 1991. PMID: 1919642 Review.

3

Activity of temozolomide in the treatment of central nervous system tumor xenografts.

Friedman HS, Dolan ME, Pegg AE, Marcelli S, Keir S, Catino JJ, Bigner DD, Schold SC Jr. Friedman HS, et al. Among authors: bigner dd. Cancer Res. 1995 Jul 1;55(13):2853-7. Cancer Res. 1995. PMID: 7796412

4

Busulfan therapy of central nervous system xenografts in athymic mice.

Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS. Aaron RH, et al. Among authors: bigner dd. Cancer Chemother Pharmacol. 1994;35(2):127-31. doi: 10.1007/BF00686634. Cancer Chemother Pharmacol. 1994. PMID: 7987988

5

Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts.

Friedman HS, Houghton PJ, Schold SC, Keir S, Bigner DD. Friedman HS, et al. Among authors: bigner dd. Cancer Chemother Pharmacol. 1994;34(2):171-4. doi: 10.1007/BF00685936. Cancer Chemother Pharmacol. 1994. PMID: 8194169

6

Cyclophosphamide therapy of medulloblastoma: from the laboratory to the clinic and back again (and again and again).

Friedman HS, Bigner SH, Bigner DD. Friedman HS, et al. Among authors: bigner sh, bigner dd. J Neurooncol. 1995;24(1):103-8. doi: 10.1007/BF01052667. J Neurooncol. 1995. PMID: 8523066 Review.

7

Prognostic implications of chromosome 17p deletions in human medulloblastomas.

Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, Friedman HS, Bigner DD, Bigner SH. Batra SK, et al. Among authors: bigner sh, bigner dd. J Neurooncol. 1995;24(1):39-45. doi: 10.1007/BF01052657. J Neurooncol. 1995. PMID: 8523074

8

Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.

Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM. Friedman HS, et al. Among authors: bigner dd. Cancer Chemother Pharmacol. 1999;43(1):80-5. doi: 10.1007/s002800050866. Cancer Chemother Pharmacol. 1999. PMID: 9923545

9

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.

Castellino RC, Elion GB, Keir ST, Houghton PJ, Johnson SP, Bigner DD, Friedman HS. Castellino RC, et al. Among authors: bigner dd. Cancer Chemother Pharmacol. 2000;45(4):345-9. doi: 10.1007/s002800050050. Cancer Chemother Pharmacol. 2000. PMID: 10755324

10

O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts--implications for clinical trials.

Keir ST, Dolan ME, Pegg AE, Lawless A, Moschel RC, Bigner DD, Friedman HS. Keir ST, et al. Among authors: bigner dd. Cancer Chemother Pharmacol. 2000;45(6):437-40. doi: 10.1007/s002800051016. Cancer Chemother Pharmacol. 2000. PMID: 10854129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters